Literature DB >> 16106317

[Nutritional status and intestinal iron absorption in children with chronic hepatic disease with and without cholestasis].

Regina Helena G da Motta Mattar1, Ramiro Anthero de Azevedo, Patrícia G L Speridião, Ulysses Fagundes Neto, Mauro Batista de Morais.   

Abstract

OBJECTIVE: To evaluate food intake, occurrence of energy-protein malnutrition and anemia, and intestinal iron absorption in children with chronic liver disease.
METHODS: The study included 25 children with chronic liver disease, 14 with cholestasis and 11 without cholestasis. The age varied between 6.5 months and 12.1 years. Intestinal iron absorption was evaluated by the increment of serum iron one hour after the ingestion of 1 mg/kg of elemental iron and by the response to oral iron therapy. Iron intestinal absorption was compared to a group with iron deficiency anemia (without liver disease).
RESULTS: The mean intake of energy and protein in the cholestatic group was higher than in patients without cholestasis. The nutritional deficit was more severe in cholestatic patients, especially with regard to height-for-age and weight-for-age indices. Anemia was found in both cholestatic group (11/14; 78.6%) and noncholestatic group (7/11; 63.6%). The cholestatic group presented lower (p < 0.05) intestinal iron absorption (90.6+/-42.1 microg/dl) than the iron deficiency anemia group (159.6+/-69.9 microg/dl). However, cholestatic patients responded to oral iron therapy. The noncholestatic group showed intestinal iron absorption similar to the iron deficiency anemia group.
CONCLUSION: The cholestatic group showed more severe nutritional deficits. Despite the evidence of lower iron intestinal absorption, cholestatic patients responded to oral iron therapy, probably, due to the coexistence of iron deficiency.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16106317

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  7 in total

1.  Dysregulation of antioxidant responses in patients diagnosed with concomitant Primary Sclerosing Cholangitis/Inflammatory Bowel Disease.

Authors:  Colin T Shearn; David J Orlicky; Dennis R Petersen
Journal:  Exp Mol Pathol       Date:  2017-11-24       Impact factor: 3.362

2.  Nutritional status of infants with neonatal cholestasis.

Authors:  Hasan Ali Yuksekkaya; Murat Cakir; Gokhan Tumgor; Masallah Baran; Cigdem Arikan; Rasit Vural Yagci; Sema Aydogdu
Journal:  Dig Dis Sci       Date:  2007-08-24       Impact factor: 3.199

3.  Predictor of Liver Biochemistry Improvement in Patients with Cytomegalovirus Cholestasis after Ganciclovir Treatment.

Authors:  Gina Puspita; Titis Widowati; Agung Triono
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2022-01-07

Review 4.  METABOLIC AND NUTRITIONAL REPERCUSSIONS OF LIVER DISEASE ON CHILDREN: HOW TO MINIMIZE THEM?

Authors:  Beatriz Polisel Mazzoni; Bruna Voltani Lessa; Patricia Zamberlan
Journal:  Rev Paul Pediatr       Date:  2021-05-26

5.  Prevalence of Iron deficiency anemia in children with liver cirrhosis: A cross-sectional study.

Authors:  Soheila Zareifar; Seyed Mohsen Dehghani; Najmeh Rahanjam; Mohammad Reza Farahmand Far
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-07-01

6.  Prevalence of malnutrition and risk of undernutrition in hospitalised children with liver disease.

Authors:  Ronghua Yu; Yizhong Wang; Yongmei Xiao; Lili Mo; Aishu Liu; Dan Li; Ting Ge; Guangjun Yu; Ting Zhang
Journal:  J Nutr Sci       Date:  2017-10-30

7.  Anthropometric, biochemical and clinical assessment of malnutrition among Egyptian children with chronic liver diseases: a single institutional cross-sectional study.

Authors:  Nehal El Koofy; Eman Mohamed Ibraheim Moawad; Mona Fahmy; Mona Anwar Mohamed; Hany Fathy Ahmed Mohamed; Ehab Mohamed Eid; Moushira Errfan Zaki; Rokaya Mohamed El-Sayed
Journal:  BMC Gastroenterol       Date:  2019-12-21       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.